StockNews.com began coverage on shares of CEL-SCI (NYSE:CVM – Free Report) in a report published on Thursday morning. The firm issued a sell rating on the stock. CEL-SCI Stock Performance NYSE:CVM opened at $1.19 on Thursday. The company has a current ratio of 1.46, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. […]
Related Keywords
, Millennium Management , Renaissance Technologies , Walleye Capital , Goldman Sachs Group Inc , A Davidson , Da Davidson , Free Report , Get Free Report , Sachs Group , Leukocyte Interleukin , Cel Sci , Nyse Cvm , Icvm , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.